Serum biomarker testing
Diagnostic TestSerum and sputum samples will be collected and biomarkers will be evaluated using ELISA
NCT Number: NCT04377958
Serum samples of asthmatic patients will be screened for serum biomarkers
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Serum and sputum samples will be collected and biomarkers will be evaluated using ELISA
Time frame: Day 1
Serum Calprotectin (pg/ml) will be measured in serum samples using a U-plex assay
Time frame: Day 1
Sputum Calprotectin (pg/ml) will be measured in sputum samples using a U-plex assay
KU Leuven
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03105843
Asthma, Bronchial Diseases
Kingston, Ontario, Canada
View Trial DetailsNCT07394127
Asthma, Asthma Chronic
Gümüşhane, Trabzon, Ordu, Giresun, Rize, Artvin, Gümüşhane, Turkey (Türkiye)
View Trial DetailsNCT03453112
Asthma, Bronchial Diseases
Hefei, Anhui, China
View Trial DetailsNCT01399411
Asthma, Autoimmune Diseases
Iowa City, Illinois, United States
View Trial Details